Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alanyl-glutamine to prevent postoperative insulin resistance in colon cancer surgery
2008-007748-33Phase 4Active
- Sponsor
- Foreest Medical School
- Start
- Dec 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of alanyl glutamine in insulin resistance (IR) and colon cancer, sponsored by Foreest Medical School. Primary endpoint: Insulin resistance. Started Dec 2008; status: active.
02
Drugs
alanyl glutamine
03
Conditions
insulin resistance (IR)colon cancer
Beyond the preview
Go deeper on 2008-007748-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007748-33.